¼¼°èÀÇ ÀÇ·á¿ë Àü»ç ¼ÒÇÁÆ®¿þ¾î ½ÃÀå
Medical Transcription Software
»óǰÄÚµå : 1782881
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 361 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,209,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,629,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÀÇ·á¿ë Àü»ç ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀåÀº 2030³â±îÁö 97¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 42¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÀÇ·á¿ë Àü»ç ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 14.7%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 97¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¼ÒÇÁÆ®¿þ¾î´Â CAGR 15.9%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 67¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼­ºñ½º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 12.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 12¾ï ´Þ·¯, Áß±¹Àº CAGR 19.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÀÇ·á¿ë Àü»ç ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº 2024³â¿¡ 12¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 21¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 19.7%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 10.7%¿Í 13.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 11.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÀÇ·á¿ë Àü»ç ¼ÒÇÁÆ®¿þ¾î ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÀÇ·á¿ë Àü»ç ¼ÒÇÁÆ®¿þ¾î´Â À½¼ºÀÇ ÅØ½ºÆ®È­¸¦ ÀÚµ¿È­ÇÏ¿© ÀÓ»ó ±â·Ï, ÀÇ»çÀÇ ¿öÅ©Ç÷οì È¿À²È­, ÇコÄÉ¾î µ¥ÀÌÅÍ °ü¸®¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ȯÀÚ ¼ö Áõ°¡, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ÀüÀÚ ÀÇ·á ±â·Ï(EHR)À¸·ÎÀÇ Àüȯ¿¡ µû¶ó ÀÇ·áÁøÀº Á¤È®¼º Çâ»ó, °ü¸® ¾÷¹« °¨¼Ò, µ¥ÀÌÅÍ Á¢±Ù¼º Çâ»óÀ» À§ÇØ AI¸¦ Ȱ¿ëÇÑ ³ìÃë ¼Ö·ç¼Ç¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. À½¼º ÀνÄ, ÀÚ¿¬¾î ó¸®(NLP), Ŭ¶ó¿ìµå ±â¹Ý Æ®·£½ºÅ©¸³¼Ç ¼­ºñ½ºÀÇ ±â¼ú Çõ½ÅÀº ÀÇ·á ¹®¼­ÀÇ ½Å¼Ó¼º, È¿À²¼º, ¾÷°è Ç¥ÁØ Áؼö¸¦ ½ÇÇöÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë Àü»ç ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀ» º¯È­½Ãų »õ·Î¿î Æ®·»µå´Â ¹«¾ùÀϱî?

ÀÇ·á Æ®·£½ºÅ©¸³¼ÇÀÇ °¡Àå Áß¿äÇÑ Æ®·»µå Áß Çϳª´Â AI¸¦ ÅëÇÑ À½¼º Àνİú NLPÀÇ ÅëÇÕÀÔ´Ï´Ù. ÃֽŠƮ·£½ºÅ©¸³¼Ç ¼ÒÇÁÆ®¿þ¾î´Â µö·¯´×°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀ» Ȱ¿ëÇÏ¿© ÀÇ·á¿ë¾î ½Äº°, ÀÇ»ç Æ¯À¯ÀÇ ¹ßÈ­ ÆÐÅÏ °¨Áö, ¹®¸ÆÀÇ Á¤È®µµ Çâ»óÀ» ½ÇÇöÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ AI¸¦ Ȱ¿ëÇÑ ¼Ö·ç¼ÇÀ» ÅëÇØ ½Ç¼ö¸¦ ÃÖ¼ÒÈ­ÇÑ ½Ç½Ã°£ À½¼º¿¡¼­ ÅØ½ºÆ®·ÎÀÇ º¯È¯ÀÌ °¡´ÉÇØÁ® ¼öÀÛ¾÷À¸·Î ÀÎÇÑ ³ìÃë ´ã´çÀÚÀÇ Çʿ伺À» ÁÙÀÌ´Â µ¿½Ã¿¡ ÀÓ»ó ¹®¼­ ÀÛ¼ºÀÇ È¿À²¼ºÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ Æ®·»µå´Â Ŭ¶ó¿ìµå ±â¹ÝÀÇ ¸ð¹ÙÀÏ Ä£È­ÀûÀÎ ³ìÃë ¼Ö·ç¼ÇÀÇ ¼ºÀåÀÔ´Ï´Ù. ÇコÄɾ ¿ø°ÝÁö ºÐ»êÇü Áø·á·Î ÀüȯµÇ°í ÀÖ´Â °¡¿îµ¥, Ŭ¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀ» ÅëÇØ ¾ðÁ¦ ¾îµð¼­³ª ÇÊ»çÇÑ ÀÇ·á ±â·Ï¿¡ Á¢±ÙÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ¼Ö·ç¼ÇÀº EHR, ¿ø°ÝÀÇ·á Ç÷§Æû, ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ǰú ¿øÈ°ÇÏ°Ô ÅëÇյǾî ÀÇ»ç´Â ½º¸¶Æ®Æù, ÅÂºí¸´, ¿þ¾î·¯ºí ±â±â¸¦ ÅëÇØ ȯÀÚÀÇ ¸Þ¸ð¸¦ ¹Þ¾Æ¾²±â ÇÒ ¼ö ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ³ìÃë ¼ÒÇÁÆ®¿þ¾î´Â µ¥ÀÌÅÍ º¸¾È, ½ºÅ丮Áö È®À强, ÇコÄÉ¾î ÆÀ °£ÀÇ Çù¾÷À» °­È­ÇÕ´Ï´Ù.

¶ÇÇÑ, Àü¹® ºÐ¾ß¿¡ ƯȭµÈ ³ìÃë ¼Ö·ç¼ÇÀÇ µîÀåµµ ½ÃÀåÀ» ÀçÆíÇϰí ÀÖ½À´Ï´Ù. ±âÁ¸ Æ®·£½ºÅ©¸³¼Ç ¼ÒÇÁÆ®¿þ¾î´Â ÀÇ·á Àü¹®¿ë¾î³ª ½Ã¼ú ¿ë¾î, Àü¹® ºÐ¾ß ƯÀ¯ÀÇ ¹®¼­ ÀÛ¼º ¿ä±¸¿¡ ´ëÀÀÇÏ´Â µ¥ ¾î·Á¿òÀ» °Þ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. À̸¦ ÇØ°áÇϱâ À§ÇØ ¹æ»ç¼±°ú, ¼øÈ¯±â³»°ú, Á¾¾ç³»°ú, º´¸®°ú, Á¤½Å°Ç°­ÀÇÇаú ³ìÃë¿¡ ¸Â°Ô AI ±â¹Ý ¼Ö·ç¼ÇÀÌ Á¶Á¤µÇ¾î ³ôÀº Á¤È®µµ¿Í ÃÖ¼ÒÇÑÀÇ Æ÷½ºÆ®¿¡µðÆÃ ¿ä±¸»çÇ×À» º¸ÀåÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¾ß¿¡ ƯȭµÈ ¸ðµ¨Àº ÀÇ»çÀÇ È¿À²¼ºÀ» ³ôÀ̰í Àü¹® º¸°í¼­ÀÇ ¿À·ù¸¦ ÁÙÀÔ´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ÀÇ·á ±â·ÏÀÇ Á¤È®¼º°ú È¿À²¼ºÀÌ ¾î¶»°Ô Çâ»óµÇ°í Àִ°¡?

½Ç½Ã°£ Æ®·£½ºÅ©¸³¼Ç, ¿¹Ãø ºÐ¼®, À½¼º ÀÎ½Ä ÀÚµ¿È­ µîÀÇ ±â¼ú ¹ßÀüÀ¸·Î ÀÇ·á¿ë Àü»ç ¼ÒÇÁÆ®¿þ¾îÀÇ ¼º´ÉÀÌ Å©°Ô Çâ»óµÇ°í ÀÖ½À´Ï´Ù. °¡Àå ¿µÇâ·Â ÀÖ´Â °³¹ß Áß Çϳª´Â AI¸¦ Ȱ¿ëÇÑ ÀÚµ¿ ¿À·ù °¨Áö ¹× ¼öÁ¤ÀÔ´Ï´Ù. ±â°èÇнÀ ¸ðµ¨ÀÌ ÇÊ»çµÈ ¸Þ¸ð¸¦ ºÐ¼®ÇÏ¿© ¹®¹ý ºÒÀÏÄ¡, ÀÇÇÐ ¿ë¾îÀÇ ¿À¿ª, Áß¿ä µ¥ÀÌÅÍ ´©¶ô µîÀ» °¨ÁöÇÏ¿© ¿À·ù ¾ø´Â ÀÓ»ó ¹®¼­¸¦ »ý¼ºÇÕ´Ï´Ù.

¶Ç ´Ù¸¥ Å« µµ¾àÀº Àü»ç ¼ÒÇÁÆ®¿þ¾î¿Í EHR ¹× ÀÓ»óÆÇ´ÜÁö¿ø½Ã½ºÅÛ(CDSS)°úÀÇ ÅëÇÕÀÔ´Ï´Ù. ÃֽŠƮ·£½ºÅ©¸³¼Ç ¼Ö·ç¼ÇÀº ȯÀÚ Â÷Æ®¿¡ ÀÚµ¿À¸·Î ÀԷµǰí, °ü·Ã º´·ÂÀ» ÃßÃâÇÏ¿© ±¸Á¶È­µÈ ¹®¼­ Çü½ÄÀ» Á¦°øÇϹǷΠ¼öÀÛ¾÷À¸·Î µ¥ÀÌÅ͸¦ ÀÔ·ÂÇÒ Çʿ䰡 ¾ø½À´Ï´Ù. À̸¦ ÅëÇØ ÀÇ»çÀÇ ÇǷθ¦ ÁÙÀ̰í, ¹®¼­ ÀÛ¼ºÀÇ È¿À²¼ºÀ» ³ôÀ̸ç, ȯÀÚ Ä¡·á¸¦ À§ÇÑ ½Ç½Ã°£ ÀÇ»ç°áÁ¤À» °­È­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

´ÙÁß È­ÀÚ Àνİú ¹è°æ ÀâÀ½ Á¦°ÅÀÇ ¹ßÀüµµ ÀÇ·á ±â·Ï ÀÛ¼ºÀÇ °³¼±À» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. AI¸¦ Ȱ¿ëÇÑ ¼ÒÇÁÆ®¿þ¾î´Â ÀÓ»ó ȯ°æ¿¡¼­ ¿©·¯ ¸íÀÇ È­ÀÚ¸¦ ½Äº°ÇÒ ¼ö ÀÖ°Ô µÇ¾ú°í, ÀÇ»ç, °£È£»ç, ȯÀÚ °£ÀÇ ´ëÈ­¸¦ Á¤È®ÇÏ°Ô ±â·ÏÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. °í±Þ ³ëÀÌÁî ĵ½½¸µ ¾Ë°í¸®ÁòÀÌ ¹è°æ ¼ÒÀ½À» ÇÊÅ͸µÇÏ¿© ÀÀ±Þ½ÇÀ̳ª ¿ø°ÝÀÇ·á ȯ°æ¿¡¼­µµ º¸´Ù Á¤È®ÇÑ ³ìÀ½ÀÌ °¡´ÉÇÕ´Ï´Ù.

ÀÇ·á¿ë Àü»ç ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

ÀÇ·á¿ë Àü»ç ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼ºÀåÀº ÀÚµ¿È­µÈ ÀÓ»ó ±â·Ï¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¿ø°ÝÀÇ·á ¹× ¿ø°ÝÁø·á ¼­ºñ½º È®´ë, Á¤È®ÇÑ È¯ÀÚ ±â·Ï¿¡ ´ëÇÑ ±ÔÁ¦ ¿ä°Ç, ÀÇ·á ¿öÅ©Ç÷ο쿡¼­ AIÀÇ ÅëÇÕ ¹ßÀü µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÀÇ»çµéÀº ¹®¼­ ÀÛ¼º¿¡ ¸¹Àº ½Ã°£À» ÇÒ¾ÖÇϰí Àֱ⠶§¹®¿¡ À½¼º ÀÎ½Ä ³ìÃë´Â °ü¸® ¾÷¹«ÀÇ ºÎ´ãÀ» ÁÙÀÌ°í »ý»ê¼ºÀ» Çâ»ó½ÃŰ´Â Áß¿äÇÑ µµ±¸°¡ µÇ°í ÀÖ½À´Ï´Ù.

¿ø°ÝÀÇ·á¿Í °¡»óÁø·áÀÇ ¿ªÇÒ È®´ëµµ Å« ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¿ø°ÝÁø·á¸¦ ¹Þ´Â ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿ø°ÝÀÇ·á Ç÷§Æû¿¡ Æ®·£½ºÅ©¸³¼Ç ¼ÒÇÁÆ®¿þ¾î°¡ ÅëÇյǾî ȯÀÚ¿ÍÀÇ »óÈ£ÀÛ¿ëÀ» ½Ç½Ã°£À¸·Î ĸóÇÏ°í ¹®¼­È­ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. À̸¦ ÅëÇØ ¼öÀÛ¾÷À¸·Î ¸Þ¸ð¸¦ ÇÒ Çʿ䰡 ¾ø¾îÁö°í, °¡»ó Áø·á°¡ È¿À²ÀûÀ¸·Î ±â·ÏµÇ¾î µðÁöÅÐ ÀÇ·á ±â·Ï¿¡ ÀúÀåµË´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ ¿øµ¿·ÂÀº ±ÔÁ¦ Áؼö ¿ä±¸ »çÇ×ÀÇ Áõ°¡ÀÔ´Ï´Ù. ¹Ì±¹ÀÇ HIPAA(ÀǷẸÇè »óÈ£¿î¿ë¼º ¹× Ã¥ÀÓ¿¡ °üÇÑ ¹ý·ü), À¯·´ÀÇ GDPR(ÀϹݰ³ÀÎÁ¤º¸º¸È£±ÔÁ¤) µî ÇコÄÉ¾î ±ÔÁ¦¿¡ µû¶ó ȯÀÚ¿ÍÀÇ »óÈ£ÀÛ¿ëÀ» ¾ÈÀüÇϰí Á¤È®ÇÏ°Ô ¹®¼­È­ÇÒ Àǹ«°¡ ÀÖ½À´Ï´Ù. ¾Ïȣȭ, °¨»ç ÃßÀû, ÄÄÇöóÀ̾𽺠°ËÁõ µµ±¸°¡ ³»ÀåµÈ AI ±â¹Ý ³ìÃë ¼ÒÇÁÆ®¿þ¾î´Â ÀÇ·á ±â°üÀÌ µ¥ÀÌÅÍ º¸¾ÈÀ» À¯ÁöÇϸ鼭 ÀÌ·¯ÇÑ ±ÔÁ¦ ±âÁØÀ» ÃæÁ·ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

ÇコÄÉ¾î ºÐ¾ß¿¡¼­ AI¸¦ Ȱ¿ëÇÑ ÀÚµ¿È­ÀÇ ºÎ»óÀº ½ÃÀå È®´ë¸¦ ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ÀÚµ¿ ÀÇ·á ±â·Ï ±â¼ú, ½Ç½Ã°£ ¸Þ¸ð ±¸Á¶È­, ¿¹Ãø Àü»ç ºÐ¼®À» ÅëÇØ ÀÇ·á ¹®¼­°¡ ´õ¿í ÇÕ¸®ÀûÀ̰í Á¤È®ÇØÁ³½À´Ï´Ù. À½¼º ÅØ½ºÆ®È­ ±â¼ú, AI¸¦ ÅëÇÑ µ¥ÀÌÅÍ ±¸Á¶È­, EHR ½Ã½ºÅÛ°úÀÇ »óÈ£¿î¿ë¼ºÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î ÀÇ·á¿ë Àü»ç ¼ÒÇÁÆ®¿þ¾îÀÇ ¹Ì·¡´Â ÀÓ»ó ¹®¼­¸¦ ÀçÁ¤ÀÇÇϰí, ÀÇ·áÀÇ È¿À²¼ºÀ» Çâ»ó½Ã۸ç, Àü ¼¼°èÀûÀ¸·Î ÀÇ»ç¿Í ȯÀÚÀÇ »óÈ£ ÀÛ¿ëÀ» °­È­ÇÒ °ÍÀÔ´Ï´Ù.

ºÎ¹®

±¸¼º¿ä¼Ò(¼ÒÇÁÆ®¿þ¾î, ¼­ºñ½º), Àü°³(Ŭ¶ó¿ìµå ±â¹Ý, ¿ÂÇÁ·¹¹Ì½º), ÃÖÁ¾»ç¿ë(º´¿ø ¹× Ŭ¸®´Ð, Áø´Ü ¼¾ÅÍ, ±âŸ ÃÖÁ¾»ç¿ë)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Medical Transcription Software Market to Reach US$9.7 Billion by 2030

The global market for Medical Transcription Software estimated at US$4.2 Billion in the year 2024, is expected to reach US$9.7 Billion by 2030, growing at a CAGR of 14.7% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 15.9% CAGR and reach US$6.7 Billion by the end of the analysis period. Growth in the Service segment is estimated at 12.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 19.7% CAGR

The Medical Transcription Software market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 19.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.7% and 13.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.7% CAGR.

Global Medical Transcription Software Market - Key Trends & Drivers Summarized

Medical transcription software is revolutionizing clinical documentation, physician workflow efficiency, and healthcare data management by automating the conversion of speech into text. With increasing patient loads, strict regulatory requirements, and the transition to Electronic Health Records (EHRs), healthcare providers are relying on AI-powered transcription solutions to enhance accuracy, reduce administrative workload, and improve data accessibility. Innovations in speech recognition, natural language processing (NLP), and cloud-based transcription services are making medical documentation faster, more efficient, and compliant with industry standards.

What Emerging Trends Are Transforming the Medical Transcription Software Market?

One of the most significant trends in medical transcription is the integration of AI-driven speech recognition and NLP. Modern transcription software now utilizes deep learning and machine learning algorithms to identify medical terminologies, detect physician-specific speech patterns, and improve contextual accuracy. These AI-powered solutions allow real-time voice-to-text conversion with minimal errors, reducing the need for manual transcriptionists while enhancing efficiency in clinical documentation.

Another key trend is the growth of cloud-based and mobile-friendly transcription solutions. With healthcare moving toward remote and decentralized care, cloud-based platforms enable anytime, anywhere access to transcribed medical notes. These solutions seamlessly integrate with EHRs, telehealth platforms, and mobile applications, allowing physicians to dictate patient notes via smartphones, tablets, or wearable devices. Cloud-based transcription software also enhances data security, storage scalability, and collaboration among healthcare teams.

The rise of specialty-specific transcription solutions is also reshaping the market. Traditional transcription software often struggles with medical jargon, procedural terminology, and specialty-specific documentation needs. To address this, AI-powered solutions are being tailored for radiology, cardiology, oncology, pathology, and mental health transcription, ensuring higher accuracy and minimal post-editing requirements. These domain-specific models enhance physician efficiency and reduce errors in specialty reports.

How Are Technological Advancements Enhancing Medical Transcription Accuracy and Efficiency?

Technological advancements in real-time transcription, predictive analytics, and voice-enabled automation are significantly improving the performance of medical transcription software. One of the most impactful developments is the use of AI-powered automatic error detection and correction. Machine learning models analyze transcribed notes for grammatical inconsistencies, misinterpretations of medical terms, and omitted critical data, ensuring error-free clinical documentation.

Another major breakthrough is the integration of transcription software with EHR and clinical decision support systems (CDSS). Modern transcription solutions automatically populate patient charts, extract relevant medical history, and provide structured documentation formats, eliminating the need for manual data entry. This reduces physician burnout, improves documentation efficiency, and enhances real-time decision-making for patient care.

Advancements in multi-speaker recognition and background noise reduction are also driving improvements in medical transcription. AI-driven software can now distinguish between multiple speakers in a clinical environment, ensuring that conversations between physicians, nurses, and patients are accurately transcribed. Advanced noise-canceling algorithms filter out background disturbances, making transcription more precise, even in emergency rooms or telehealth settings.

What Factors Are Driving the Growth of the Medical Transcription Software Market?

The growth in the medical transcription software market is driven by several factors, including the rising demand for automated clinical documentation, the expansion of telemedicine and remote healthcare services, regulatory requirements for accurate patient records, and the increasing integration of AI in healthcare workflows. Physicians spend significant time on documentation, making speech-enabled transcription a critical tool for reducing administrative workload and improving productivity.

The expanding role of telemedicine and virtual healthcare consultations is another major driver. With more patients receiving remote care, transcription software is being integrated into telehealth platforms to capture and document patient interactions in real time. This eliminates the need for manual note-taking, ensuring that virtual visits are efficiently recorded and stored within digital health records.

Another key driver is increasing regulatory compliance requirements. Healthcare regulations, such as HIPAA (Health Insurance Portability and Accountability Act) in the U.S. and GDPR (General Data Protection Regulation) in Europe, mandate secure and accurate documentation of patient interactions. AI-powered transcription software with built-in encryption, audit trails, and compliance verification tools helps healthcare organizations meet these regulatory standards while maintaining data security.

The rise of AI-powered automation in healthcare is further accelerating market expansion. Automated medical scribe technology, real-time note structuring, and predictive transcription analytics are making medical documentation more streamlined and accurate. With continued advancements in speech-to-text technology, AI-driven data structuring, and interoperability with EHR systems, the future of medical transcription software is set to redefine clinical documentation, improve healthcare efficiency, and enhance physician-patient interactions worldwide.

SCOPE OF STUDY:

The report analyzes the Medical Transcription Software market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software, Service); Deployment (Cloud-based, On-Premise); End-Use (Hospitals & Clinics, Diagnostic centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â